Perflow Medical expands IP coverage for Stream and Cascade devices

Stream Dynamic Neuro-Thrombectomy Net

Perflow Medical has announced the issuance of four international patents that expand the global intellectual property (IP) coverage for the novel Stream Dynamic Neuro-Thrombectomy Net and Cascade Non-Occlusive Remodeling Net.

Perflow’s global portfolio of eight issued patents includes two new patents from the European Patent Office (EPO), one from the China National Intellectual Property Administration (CNIPA), and one from the Japanese Patent Office (JPO). The new patents build on Perflow’s foundational IP coverage of real-time user controlled braided devices for neurovascular applications, including stroke and aneurysm repair.

Specialising in the treatment of complex neurovascular disorders, Perflow’s CEREBRAL NET technology platform is designed to expand treatment options with real-time control and overall improved device performance.

The company currently has two commercial products with CE Mark available for use in Europe, with a third product in late-stage development. The Stream Net, the company’s first product, has been successfully used across Europe and provides full control and dynamic wall apposition during the treatment of acute ischaemic stroke. The Cascade Net, which was launched last year, is the first and only device that allows blood flow without the risk of coil entanglement during embolisation of intracranial aneurysms. Both devices allow the physician to manipulate the net diameter, length, and radial force to optimise contact with the vessel wall and improve control through tortuous anatomy during neurovascular procedures.

“In addition to expanding the commercial reach of our line of neurovascular solutions, we continue to fortify our global IP portfolio to protect, expand, and improve the use of our braiding technology across markets,” commented Danny Farin, CEO of Perflow Medical. “Both the Stream and Cascade devices empower physicians with superior control and more predictable handling to improve patient outcomes and physician experience.”

Clinical data regarding the Stream and Cascade devices will be presented during the ABC-WIN Seminar, January 13th-18th in Val d’lsère, France.


Please enter your comment!
Please enter your name here